Nuwellis announced the pricing of a public offering of 11,250,000 shares of its common stock and warrants to purchase up to an aggregate of 16,875,000 shares of its common stock at a combined public offering price $0.24 per share and associated warrant. Each share of common stock is being sold together with one warrant to purchase one and a half shares of common stock. The warrants will have an exercise price of $0.40 per share, are exercisable immediately upon issuance, and will expire five years following the date of issuance. The offering is expected to close on or about April 30, 2024, subject to the satisfaction of customary closing conditions. Roth Capital Partners is acting as exclusive placement agent for the offering. The gross proceeds to Nuwellis from the offering, before deducting the placement agent fees and other offering expenses, are expected to be approximately $2.7 million. Nuwellis intends to use the net proceeds from the offering for working capital and for general corporate purposes, including for continued investments in its commercialization efforts.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUWE:
- Nuwellis Announces Pricing of $2.7 Million Public Offering
- Nuwellis: Henry Ford offers ultrafiltration therapy to heart failure patients
- Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health
- Nuwellis, Inc. on the Brink: Racing Against Time to Avoid Nasdaq Delisting
- Nuwellis announces results from clinical data anaylses of AVOID-HF trial